Research location
Brescia
BS, Italy
Advertisement
Research activity in Brescia
BS, ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 79 trials and 84 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Brescia
77 linked trials · page 1 of 2Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk FactorsNCT07731191 · 2026-06-24 · 2 site observations
RECRUITING
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate CancerNCT07093801 · 2025-07-30 · 1 site observation
RECRUITING
stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective DatabaseNCT07397585 · 2025-02-25 · 1 site observation
RECRUITING
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionNCT06736574 · 2024-12-19 · 1 site observation
RECRUITING
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsNCT06033950 · 2024-08-20 · 1 site observation
RECRUITING
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric DisordersNCT06886945 · 2024-04-09 · 1 site observation
RECRUITING
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.NCT05939414 · 2024-03-12 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaNCT05562466 · 2023-05-11 · 1 site observation
RECRUITING
Neurosurgical Outcome NetworkNCT06724029 · 2022-12-05 · 2 site observations
RECRUITING
SRT Versus SRT+ADT in Prostate CancerNCT05019846 · 2021-09-30 · 1 site observation
RECRUITING
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive VariablesNCT07533084 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"NCT06871501 · 2025-03-01 · 1 site observation
NOT_YET_RECRUITING
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisNCT06655896 · 2024-10-29 · 1 site observation
ACTIVE_NOT_RECRUITING
A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart FailureNCT06142383 · 2023-12-12 · 1 site observation
TERMINATED
BRING-UP 3 Heart FailureNCT06279988 · 2023-09-15 · 1 site observation
UNKNOWN
A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931NCT05730023 · 2023-02-01 · 1 site observation
UNKNOWN
At Home Gamma tACS in Alzheimer's Disease (tACS@Home)NCT05643326 · 2022-12-10 · 1 site observation
COMPLETED
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.NCT05562934 · 2022-11-08 · 1 site observation
COMPLETED
Impact of Mayzent on aSPMS Patients in a Long-term NIS in ItalyNCT05376579 · 2022-06-17 · 1 site observation
COMPLETED
Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical PracticeNCT05250011 · 2022-04-19 · 1 site observation
COMPLETED
All-in-One Prostate Cancer Staging with MRINCT06071195 · 2021-12-22 · 1 site observation
UNKNOWN
Modulators of Gamma tACS in Alzheimer's Disease (Mod-GammAD)NCT04842955 · 2021-03-10 · 1 site observation
COMPLETED
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationNCT04699188 · 2021-02-24 · 1 site observation
ACTIVE_NOT_RECRUITING
INTERFACE: hIv patieNts TracER For clinicAl assistanCe and rEsearch During COVID 19NCT05711680 · 2021-01-18 · 1 site observation
UNKNOWN
Outcome pRognostication of Acute Brain Injury With the NeuroloGical Pupil indExNCT04490005 · 2020-11-02 · 1 site observation
COMPLETED
Gamma tACS in Alzheimer's DiseaseNCT04515433 · 2020-08-20 · 1 site observation
COMPLETED
Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"NCT04312503 · 2020-07-13 · 1 site observation
COMPLETED
Clinical Validation of a Combinatorial Pharmacogenomic Approach in Major Depressive DisorderNCT04615234 · 2020-02-01 · 1 site observation
UNKNOWN
Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective TrialNCT03413007 · 2018-02-09 · 1 site observation
UNKNOWN
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus FulvestrantNCT03439046 · 2018-02-02 · 1 site observation
TERMINATED
A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With AntipsychoticsNCT03693794 · 2017-12-15 · 1 site observation
UNKNOWN
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled AsthmaNCT03226392 · 2017-10-31 · 1 site observation
COMPLETED
Impact of Different Integrase Inhibitor Based Regimen on Immune Activation Among HIV naïve Patient (INTATTI)NCT03280940 · 2017-09-01 · 1 site observation
COMPLETED
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseNCT03131453 · 2017-08-03 · 1 site observation
TERMINATED
BLITZ Heart FailureNCT03661060 · 2017-03-08 · 2 site observations
COMPLETED
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MINCT02924727 · 2016-12-09 · 1 site observation
COMPLETED
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCNCT02941926 · 2016-11-30 · 2 site observations
COMPLETED
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody AvelumabNCT02926196 · 2016-06-17 · 1 site observation
COMPLETED
Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.NCT02563067 · 2015-12-03 · 1 site observation
COMPLETED
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET AmplificationNCT02468661 · 2015-09-23 · 1 site observation
TERMINATED
Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)NCT02414139 · 2015-06-11 · 1 site observation
COMPLETED
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.NCT02422615 · 2015-06-09 · 1 site observation
COMPLETED
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)NCT02299505 · 2015-04-09 · 1 site observation
COMPLETED
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLCNCT02364999 · 2015-04-01 · 1 site observation
COMPLETED
CINC424A2X01B Rollover ProtocolNCT02386800 · 2015-03-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Pre-operative Zoledronate in Triple Negative Breast CancerNCT02347163 · 2015-02-03 · 1 site observation
TERMINATED
Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer PatientsNCT02511639 · 2014-07-30 · 1 site observation
COMPLETED
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection FractionNCT01920711 · 2014-07-18 · 1 site observation
COMPLETED
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart FailureNCT01982292 · 2014-05-01 · 1 site observation
COMPLETED
Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal WomenNCT01923168 · 2014-03-11 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.